Clinical practice guidelines for breast cancer rehabilitation
Abstract
BACKGROUND: Despite strides in early detection and management of breast cancer, the primary treatments for this disease continue to result in physical impairments for some of the nearly 3 million people diagnosed annually. Over the past decade, evidence‐based clinical practice guidelines (CPGs) have been developed with goals of preventing and ameliorating these impairments. However, translation of these guidelines into clinical practice needs to be accelerated.METHODS: Relevant health science databases (2001‐2011) were searched to identify CPGs on breast cancer rehabilitation for the following impairments: upper extremity restrictions, lymphedema, pain, fatigue, chemotherapy‐induced peripheral neuropathy, treatment‐related cardiotoxicity, bone health, and weight management.RESULTS: Recommendations from 19 relevant CPGs were first summarized by impairment within tables; commonalities across guidelines, within each impairment, were then synthesized within the article. The CPGs were rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II); wide variability was noted in rigor of development, clarity of presentation, and stakeholder involvement. The most rigorous and comprehensive of those rated was the adult cancer pain guideline from the Scottish Intercollegiate Guidelines Network.CONCLUSIONS: Based on a large body of evidence published in recent years, including randomized trials and systematic reviews, there is an urgent need for updating the guidelines on upper extremity musculoskeletal impairments and lymphedema. Furthermore, additional research is needed to provide an evidence base for developing rehabilitation guidelines on management of other impairments identified in the prospective surveillance model, eg, arthralgia. Cancer 2012;118(8 suppl):. © 2012 American Cancer Society.Keywords
This publication has 41 references indexed in Scilit:
- Development of the AGREE II, part 2: assessment of validity of items and tools to support applicationCanadian Medical Association Journal, 2010
- Development of the AGREE II, part 1: performance, usefulness and areas for improvementCanadian Medical Association Journal, 2010
- Upper extremity impairments in women with or without lymphedema following breast cancer treatmentJournal of Cancer Survivorship, 2010
- Inconsistent Evidence: Analysis of Six National Guidelines for Vaginal Birth After Cesarean SectionBirth, 2010
- Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of lifeHealth and Quality of Life Outcomes, 2010
- Recent advances in breast cancer radiotherapy: Evolution or revolution, or how to decrease cardiac toxicity?World Journal of Radiology, 2010
- Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic reviewBMC Cancer, 2009
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk ReductionJournal of Clinical Oncology, 2009
- Progressive resistance training in breast cancer: a systematic review of clinical trialsBreast Cancer Research and Treatment, 2007
- The treatment of lymphedema related to breast cancer: a systematic review and evidence summarySupportive Care in Cancer, 2004